You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for Patent: 6,692,763

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,692,763

Title:	Methods for treating postmenopausal women using ultra-low doses of estrogen
Abstract:	The present invention provides methods for treating physical conditions resulting from postmenopausel estrogen decline in a postmenopausel subject, and in particular methods for reducing the risk of osteoporotic bone fractures in a postmenopausal subject. The present invention also provides a kit for carrying out the methods of the present invention.
Inventor(s):	Cummings; Steven R. (Mill Valley, CA), Ettinger; Bruce (San Francisco, CA), Ellman; Herman (Mountain Lakes, NJ)
Assignee:	The Regents of the University of California (Oakland, CA) Kaiser Foundation Health Plan, Inc. (Oakland, CA) The Permanente Medical Group, Inc. (Oakland, CA) Berlex Laboratories, Inc. (Richmond, CA)
Application Number:	09/554,789
Patent Claim Types: see list of patent claims	Use; Delivery; Device;

Drugs Protected by US Patent 6,692,763

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,692,763

PCT Information
PCT Filed	November 21, 1998	PCT Application Number:	PCT/US98/24677
PCT Publication Date:	June 03, 1999	PCT Publication Number:	WO99/26631

International Family Members for US Patent 6,692,763

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	291430	⤷ Try a Trial
Austria	383862	⤷ Try a Trial
Australia	1591499	⤷ Try a Trial
Australia	760108	⤷ Try a Trial
Brazil	9814984	⤷ Try a Trial
Canada	2306881	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.